L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,450.00
-140.00 (-2.50%)
At close: Sep 11, 2026

L&K Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,6413,1783,8355,0477,39516,108
Short-Term Investments
16,6083,10816,1087,7295,6083,108
Cash & Short-Term Investments
21,2496,28619,94312,77613,00319,216
Cash Growth
59.22%-68.48%56.10%-1.75%-32.33%133.88%
Accounts Receivable
25,73717,91214,9809,8395,7801,526
Other Receivables
552.51739.65290.261,066223.05635.92
Receivables
26,28918,93316,01510,9056,0032,162
Inventory
38,29234,65824,55119,08916,36613,856
Prepaid Expenses
413.13680.38525.95656.55444.63688.1
Other Current Assets
1,113612.062,532990.85330.622,042
Total Current Assets
87,35661,17063,56644,41736,14737,964
Property, Plant & Equipment
10,9949,61710,0059,0128,5149,271
Long-Term Investments
579.03644.53577.51,04964.151,203
Other Intangible Assets
1,2051,059998.17798.73715.111,209
Long-Term Accounts Receivable
2,8814,1401,8071,2812,3855,200
Long-Term Deferred Tax Assets
5,3005,2775,0095,5163,9023,591
Long-Term Deferred Charges
----106.09223.63
Other Long-Term Assets
1,3531,375798.55387.38829.96623.29
Total Assets
109,67083,48383,06162,76252,66359,285

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3,6423,7813,3472,0472,437498.73
Accrued Expenses
2,003963.43851.44685.87589.86606.95
Short-Term Debt
25,36515,27920,55810,04020,4066,692
Current Portion of Long-Term Debt
1,1001,1008001002,800-
Current Portion of Leases
468.95706.84669.07828.69750.57636.63
Current Income Taxes Payable
5.29205.087.290.3554.090.89
Other Current Liabilities
13,61616,29612,8419,06210,9434,177
Total Current Liabilities
46,20038,33239,07422,76337,98112,613
Long-Term Debt
5005001,0001,700-13,608
Long-Term Leases
1,7821,562369.63845.161,2441,518
Pension & Post-Retirement Benefits
3,3153,1193,0572,2321,5741,330
Long-Term Deferred Tax Liabilities
1,1601,2161,5691,3611,047-
Other Long-Term Liabilities
168.56118.911,9583,27455.375,429
Total Liabilities
53,12544,84847,02832,17541,90234,499

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
11,17610,8939,9689,9686,7036,696
Additional Paid-In Capital
80,37773,69290,38690,38668,17467,992
Retained Earnings
-24,967-40,867-58,746-67,849-65,348-51,884
Treasury Stock
-0.09-0.09-0.09-0.09-0.09-0.09
Comprehensive Income & Other
-2,8451,759887.932,8462,7401,663
Total Common Equity
63,74045,47742,49635,35112,26824,467
Minority Interest
-7,196-6,842-6,463-4,764-1,507319.82
Shareholders' Equity
56,54538,63536,03330,58710,76224,787
Total Liabilities & Equity
109,67083,48383,06162,76252,66359,285

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
29,21619,14823,39713,51325,20122,456
Net Cash (Debt)
-7,967-12,861-3,454-737.76-12,198-3,240
Net Cash Growth
------
Net Cash Per Share
-370.33-632.68-158.80-45.50-910.57-242.05
Filing Date Shares Outstanding
22.3521.7919.9419.9413.4113.39
Total Common Shares Outstanding
22.3521.7919.9419.9413.4113.39
Working Capital
41,15722,83824,49221,654-1,83425,351
Book Value Per Share
2851.762087.382131.561773.17915.171826.89
Tangible Book Value
62,53544,41841,49834,55311,55323,258
Tangible Book Value Per Share
2797.842038.782081.501733.11861.821736.61
Land
2,594737.02737.02737.02737.02737.02
Buildings
3,3732,5022,5022,5022,5022,502
Machinery
11,18416,00616,49114,30712,33011,671
Construction In Progress
-2559---